Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

BACKGROUND: In models of dopaminergic neuronal loss, the dopamine agonist pramipexole has exhibited neuroprotective properties. The Pramipexole On Underlying Disease (PROUD) study was designed to identify whether early versus delayed pramipexole initiation has clinical and neuroimaging benefits in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schapira, Anthony HV, McDermott, Michael P, Barone, Paolo, Comella, Cynthia L, Albrecht, Stefan, Hsu, Helen H, Massey, Daniel H, Mizuno, Yoshikuni, Poewe, Werner, Rascol, Olivier, Marek, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714436/
https://www.ncbi.nlm.nih.gov/pubmed/23726851
http://dx.doi.org/10.1016/S1474-4422(13)70117-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714436/
https://www.ncbi.nlm.nih.gov/pubmed/23726851
http://dx.doi.org/10.1016/S1474-4422(13)70117-0

Ejemplares similares